Clinical Trial: The Management of Necrotizing Soft Tissue Infection Wounds with Cytal(R) Wound Matrix and MicroMatrix(R)

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06857708) titled 'The Management of Necrotizing Soft Tissue Infection Wounds with Cytal(R) Wound Matrix and MicroMatrix(R)' on Feb. 27.

Brief Summary: This is a prospective, pilot, parallel group, randomized controlled trial with 1:1 allocation. This will be a single center study coordinated at the Cleveland Clinic Foundation (CCF) Main Campus in Cleveland, Ohio. Data will be collected in a secure manner using REDCap housed at CCF. The study will consist of 2 arms: treatment with Cytal(R) Wound Matrix 2-Layer and MicroMatrix(R) (Integra LifeSciences, Plainsboro Township, NJ, U.S.A.) versus standard of care dressings. Wound debridement procedures will...